Ovarian cancer and antidepressants
暂无分享,去创建一个
[1] M. Lai,et al. Persistence of antidepressant treatment for depressive disorder in Taiwan. , 2013, General hospital psychiatry.
[2] M. Rapanelli,et al. Antidepressants: influence on cancer and immunity? , 2013, Life sciences.
[3] M. Lai,et al. Utilization of antidepressants in Taiwan: a nationwide population‐based survey from 2000 to 2009 , 2012, Pharmacoepidemiology and drug safety.
[4] W. Su,et al. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. , 2011, The Lancet. Oncology.
[5] Herng‐Ching Lin,et al. Increased risk of cancer subsequent to severe depression--a nationwide population-based study. , 2011, Journal of affective disorders.
[6] J. Myers,et al. Antidepressants and Breast and Ovarian Cancer Risk: A Review of the Literature and Researchers' Financial Associations with Industry , 2011, PloS one.
[7] A. Gross,et al. Depression and cancer risk: 24 years of follow-up of the Baltimore Epidemiologic Catchment Area sample , 2010, Cancer Causes & Control.
[8] A. Martelli,et al. Genotoxic and carcinogenic effects of antipsychotics and antidepressants. , 2009, Toxicology.
[9] L. de Jong-van den Berg,et al. Selection of controls in case-control studies on maternal medication use and risk of birth defects. , 2007, Birth defects research. Part A, Clinical and molecular teratology.
[10] A. Berchuck,et al. Antidepressant Medication Use for and Risk of Ovarian Cancer , 2005, Obstetrics and gynecology.
[11] H. Sternbach. Are antidepressants carcinogenic? A review of preclinical and clinical studies. , 2003, The Journal of clinical psychiatry.
[12] B. Doebbeling,et al. Relationship Between Depression and Pancreatic Cancer in the General Population , 2003, Psychosomatic medicine.
[13] David Spiegel,et al. Depression and cancer: mechanisms and disease progression , 2003, Biological Psychiatry.
[14] S. Heckbert,et al. Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications , 2002, Cancer Causes & Control.
[15] S. Shapiro,et al. Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States) , 2000, Cancer Causes & Control.
[16] J. Olsen,et al. Antidepressant medications and risk for cancer. , 2000, Epidemiology.
[17] J. Baron,et al. Psychotropic medication use and risk of epithelial ovarian cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[18] M. Cotterchio,et al. Do antidepressants cause, promote, or inhibit cancers? , 1995, Journal of clinical epidemiology.
[19] D. Cramer,et al. Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States) , 1995, Cancer Causes & Control.
[20] H. Iishi,et al. Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane. , 1993, Carcinogenesis.
[21] Jiangang,et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. , 1992, Cancer research.
[22] R. Deyo,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.
[23] J K McLaughlin,et al. Selection of controls in case-control studies. III. Design options. , 1992, American journal of epidemiology.
[24] R. Linkins,et al. Depressed mood and development of cancer. , 1990, American journal of epidemiology.
[25] K. Rothman. Induction and latent periods. , 1981, American journal of epidemiology.
[26] Organización Mundial de la Salud. Guidelines for ATC classification and DDD assignment , 1996 .